Reducing Urban Cervical Cancer Disparities Study

This study is testing different ways to help women attend their follow-up appointments after an abnormal cervical cancer screening test. It's called the Health Enhancement Resource System (HERS) intervention. HERS uses text messages to remind you about appointments and help with any issues that might keep you from going. Some participants might also receive health coaching over the phone if they miss an appointment. The study wants to see if these methods can improve attendance at your first colposcopy (a procedure to look at your cervix more closely) appointment. They are looking for women aged 18 to 90 who have been referred for a colposcopy, can speak English, and have a cell phone with texting ability. The study is currently recruiting participants.

Study design
This study is an interventional study planning to enroll 546 women. It is comparing different behavioral interventions to improve appointment attendance.
What's involved
You would receive phone calls, notification letters, and/or text messages reminding you about your appointments. Some participants might also receive health coaching calls.
Compensation
Not stated in the trial record.
Follow-up
Your attendance at the baseline colposcopy appointment will be measured for up to 3 months. Some participants will also have reminders for 12-month follow-up appointments.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06416150

Reducing Urban Cervical Cancer Disparities

Recruiting
NAAges 18–90InterventionalScreening
Fox Chase Cancer Center
~546 participants
Updated 2024-10-26 on ClinicalTrials.gov
What's tested:Stage 1 SOCStage 1 HERSStage 2 HERSStage 2 HERS+HCStage 3 SOCStage 3 HERS

At a glance

Recruiting sites
3 of 3 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Attendance at baseline colposcopy appointment
Measured over Up to 3 months post-baseline
Cervical Cancer
Papilloma Viral Infection
3 sites across 2 states
Pennsylvania2
New Jersey1
  • Suzanne M Miller, PhD · PRINCIPAL_INVESTIGATOR · Fox Chase Cancer Center

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

18 to 90 years of age (screening is still recommended for some women over 65-depending on screening and medical history and proceeds until age 90 in the study's clinic recruitment sites),
referral for colposcopic evaluation at the clinic sites,
able to communicate with ease in English,
have a cell phone with texting ability, and
competent to give consent.

Exclusion

are pregnant at the time of recruitment,
display current evidence or have a history of positive invasive carcinoma of the cervix, or
require follow-up but not a colposcopy.
  • Attendance at baseline colposcopy appointmentUp to 3 months post-baseline

    Patient attendance or non-attendance at baseline colposcopy appointment assessed via appointment attendance history in electronic medical records